- About this Journal
- Abstracting and Indexing
- Aims and Scope
- Annual Issues
- Article Processing Charges
- Articles in Press
- Author Guidelines
- Bibliographic Information
- Citations to this Journal
- Contact Information
- Editorial Board
- Editorial Workflow
- Free eTOC Alerts
- Publication Ethics
- Reviewers Acknowledgment
- Submit a Manuscript
- Subscription Information
- Table of Contents
Evidence-Based Complementary and Alternative Medicine
Volume 2012 (2012), Article ID 506978, 10 pages
The Relationship between Complementary and Alternative Medicine Use and Breast Cancer Early Detection: A Critical Review
School of Population and Public Health, Faculty of Medicine, University of British Columbia, 2206 East Mall, Vancouver, BC, V6T 1Z3, Canada
Received 13 September 2012; Accepted 30 November 2012
Academic Editor: R. Govindarajan
Copyright © 2012 Laura C. Dale and Carolyn C. Gotay. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
Objective. Complementary and alternative medicine (CAM) use is prevalent. Concurrently, breast cancer is the most common cancer in women worldwide, with early detection techniques widely available. This paper examined the overlap between participation in allopathic breast cancer early detection activities and CAM use. Methods. A systematic review examined the association between breast screening behaviors and CAM use. Searches were conducted on the PubMed, Embase, CINAHL, and NCCAM databases and gray literature between 1990 and 2011. STROBE criteria were used to assess study quality. Results. Nine studies met the search criteria. Four focused on CAM use in women at high breast cancer risk and five on average risk women. CAM use in women ranged from 22% to 82% and was high regardless of breast cancer risk. Correlations between CAM use and breast cancer early detection were not strong or consistent but significant relationships that did emerge were positive. Conclusions. Populations surveyed, and measures used to assess CAM, breast cancer screening, and correlates, varied widely. Many women who obtained allopathic screening also sought out CAM. This provides a foundation for future interventions and research to build on women’s motivation to enhance health and develop ways to increase the connections between CAM and allopathic care.
Complementary and alternative medicine (CAM) is defined as medical practices infrequently taught in medical schools nor widely available in hospitals, the latter being defined as “allopathic medicine” . According to the National Center for Complementary and Alternative Medicine (NCCAM), CAM can be described using broad categories: that is, natural products, mind body practices, manipulative and body-based practices, and other approaches . Over time, CAM practices may become accepted and integrated into allopathic medicine .
In a recent national survey of Americans, most people using CAM did so in complement with allopathic medicine . CAM usage was positively associated with the number of personal health conditions and the number of doctor visits in the past 12 months. Only a small percentage used CAM to replace allopathic medicine and such “alternative medicine users” may have poorer health than complementary users . In addition to many cultural factors contributing to variations in CAM use, it is important to better understand how CAM use and health practices influence and inform each other.
A nationally representative study found that women in better health reported higher CAM use . CAM users tend to have better health behaviors, with more physical activity, limited alcohol consumption, not smoking , and following a healthy diet , all of which are independently associated with CAM use. A survey of Medicare supplement plan enrollees found that 42% used CAM specifically for health improvements . Since CAM users are highly involved in health practices, we hypothesized that they may also be more inclined to adhere to preventive strategies based in allopathic medicine, such as cancer screening.
Breast cancer is the most commonly diagnosed cancer in women worldwide, with 1.38 million new cases and 458,000 deaths in 2008 . Using early detection interventions, breast cancer can be diagnosed at an early stage when successful treatment is more likely. Multiple agencies and organizations around the world support mammography as the most reliable way to find breast cancer early, particularly in women 50 and older [10, 11]. A professional clinical breast exam (CBE) and “knowing one’s breasts” or breast self-examination (BSE) are also recommended by some organizations [12, 13].
We were interested in learning whether participation in allopathic breast cancer early detection activities is associated with CAM use for women at both high and average risk of breast cancer. This paper provides a critical review of the literature to identify CAMs used, correlates of use, methodological strengths and weaknesses of the literature, and suggestions for future research and practice.
References were identified through PubMed and Embase database searches for 1990–2011. For PubMed, Mesh terms included “complementary therapies/utilization” AND “health behaviors,” and “breast neoplasms/prevention and control” AND “complementary therapies/utilization.” In Embase, similar search criteria were used with keywords including the explosion of “breast neoplasms” to include the “prevention” subheading AND the explosion of “complementary therapies” to include all subheadings. We also searched major Canadian government documents and other gray literature sources including Cumulated Index to Nursing and Allied Health Literature (CINAHL), the NCCAM website research database, and Google, and identified no additional papers.
The Strengthening the Reporting of Observational Studies in Epidemiology (STROBE) statement was used as a guideline to ensure a high quality of research in this review . A checklist of 22 items included indicators of study design, participant eligibility, variable assessment, potential bias, statistical methods, outcome data, and generalizability. Each paper was assessed according to these indicators and is fully available upon request. The STROBE statement was not used as tool to assess the methodological quality of the studies.
We included all forms of CAM as described by the authors and excluded papers examining women currently or previously diagnosed with breast cancer as breast cancer screening recommendations differ vastly for these women. Use of self-reported or medical record-based mammography, BSE, and CBE were the indications of allopathic breast cancer early detection used here.
Results for CAM use and its association with breast screening behaviors are summarized separately for women at high and normal genetic risk for breast cancer. We support this separation as it has been suggested that many women at high-risk for breast cancer display signs of extreme cancer anxiety, leading to increased breast screening tendencies .
All studies included in the review were summarized using their description of the defined study population, participant response rate, data collection methods and analytic procedures.
Table 1 summarizes nine studies (comprising 10 papers) that met the search criteria. Four studies focused on CAM use in women at high breast cancer risk (based on participation in a genetic testing or familial risk clinic or study), and five on average risk women. Most studies were based in the US, and two in Australia. Sample sizes ranged from a clinic-based sample of 104 [14, 15] to a large insurance claim database study with over 71,000 women . A majority collected data through mailed questionnaires with response rates ranging 59%–86%. Eight of nine studies measured CAM through dichotomous responses regarding use of a series of CAM modalities. The exception was a records-based study where CAM use was extracted from claims data, which reported four CAM therapies paid for by the health insurance plan . Numbers and types of CAMs queried varied considerably from one study to another, ranging from eight to 35. CAM content varied as well, with healthy diet considered a CAM in one study but not others. The period in which CAM use was queried ranged from “ever use” to “past year” with only one study assessing CAM use over two years . Regarding breast screening, there was considerable variability in what was asked and the time frame used; mammography, CBE, and BSE were all frequently assessed.
3.1. Prevalence and Types of CAM Use
Table 1 indicates a wide range of prevalence of CAM use, ranging from 8.3%  to 82% . The lowest figure listed is difficult to interpret since it is based on the overall study sample, which included both men and women aged 18 and older ; no information was provided regarding CAM use in subpopulations comparable to most papers reported here: that is, middle aged women. CAM use in the four studies of women at increased breast cancer risk was 42% , 50% , 55% , 58% , and 69% (without prayer included) . In studies that reported data specific to women, rates went from 22%  to 46% , 50% , and 82% . The data indicate that CAM is used in a majority or a large minority of women regardless of risk status. Many women, in fact most, used more than one kind of CAM. Field et al.  reported that one woman used 26 different kinds of CAM.
Table 2 provides a summary of the kinds of CAMs reported. The range is broad and includes the full range of approaches delineated by NCCAM. Each study, however, assessed only a subset of the total therapies possible. The most commonly queried therapies were acupuncture, massage therapy, and meditation. CAM definitions used varied, with most studies omitting healthy eating and nutrition or specific diets. The controversial role of prayer as a CAM was highlighted in one study , which computed CAM rates with and without prayer, given its high endorsement as part of everyday life.
CAM use was not assessed in a consistent way. The time frame for CAM use varied, from over the past month, to within the past year, to the past two years. Often CAM use was assessed through recall or prompting, with respondents asked to select those that they have used in the given time frame. In contrast, DiGianni’s studies [14, 15] required participants to recall the types of CAM used from memory, with memory recalls aided by suggestions of major CAM categories. It is unclear how the assessment approach may have affected responses.
3.2. Is CAM Use Associated with Screening Behaviors for Breast Cancer?
3.2.1. Women at High Risk of Breast Cancer
Of the four studies in women at increased breast cancer risk, two found no statistically significant association between CAM use and BSE  or mammograms . Myers et al.  found statistically significant positive relationships between CBE, BSE, and mammography in univariate analyses, which disappeared after taking account of covariates in multivariate analysis. A fourth paper found a weak but statistically significant inverse relationship between BSE frequency and CAM use, such that women performing self exams less than once a month were more likely to use CAM .
3.2.2. Women at Average Risk of Breast Cancer
Five studies examined women at non-increased breast cancer risk, and four of these assessed mammography. Two studies reported positive associations between CAM and mammography [4, 7], whereas two studies [16, 18] found no relationship. Downey et al. found that naturopathy had a significant negative association with mammography, while massage had a significant positive association. This study also looked at alternative therapy use—that is, using CAM rather than allopathic medicine during the period of observation. The researchers found that women who used CAM as well as biomedical care (i.e., complementary therapy users) were more likely to have a mammogram, whereas those who used CAM as an alternative and did not see a physician, were less likely to obtain mammographic screening .
One study found that herbal therapies and nutritional approaches but not phytoestrogens, were significantly correlated with BSE over the previous two years .
3.3. Correlates of CAM Use
Assessing correlates of CAM use was limited since some studies reported only relationships for the overall study population, whereas others focused on a specific target group. Nonetheless, certain trends stand out. Eight of nine studies found that higher education was linked with more CAM use [4, 7, 16–21] and most found that higher CAM use was linked with being younger [4, 7, 18, 21] and having better health behaviors [7, 15, 17, 18, 20]. These findings are consistent with other CAM literature . Higher CAM use was linked with higher anxiety or worry in several studies [15, 17, 19] and with a lower perceived breast cancer risk [15, 17].
This paper reviewed the literature on CAM use in women participating in early detection for breast cancer. The studies were high quality in terms of defining their study populations, response rates (all reported response rates of 59% or greater), well-defined data collection methods, and analytic procedures that used both univariate and multivariate strategies.
We identified nine studies that reflected a range of populations and assessment techniques. While the heterogeneity of the research makes drawing firm conclusions difficult, some findings are of particular interest. CAM use is common among women, regardless of risk status. Congruent with previous research, those who relied solely on CAM therapies as an alternative to conventional medicine were less likely to obtain mammograms whereas women who used CAM as a complement to allopathic medicine were more likely to be screened. Of particular interest is the positive association found for women who used massage therapy. Many barriers have been identified, including feelings of embarrassment or modesty, which prevent women from receiving breast exams . Massage therapy could be a positive way to decrease these barriers, as individuals receiving massage had a higher body image perception, possibly due to positive effects of being physically touched . This demonstrates the possible ways that CAM and allopathic medicine could complement one another and increase the odds that a woman will feel comfortable receiving a mammogram and will seek one out.
Literature in the area of soy consumption and breast cancer is controversial and to our surprise, seven studies did not directly assess soy intake. In higher soy-consuming cultures, mammographic densities have been positively related to soy intake  and dense breast tissue poses difficulties for effective mammographic breast cancer screening. It would have thus been important to have had additional data on the soy-breast screening relationship as high soy consuming women may have added benefits from increased breast screening. It is recognized that soy consumption, alongside other CAM practices, could have been captured in some questionnaires through “long answer” or “other” questions. It is positive that the findings from this review suggest that women with higher CAM use also have higher rates of breast screening procedures. Much more research in the area of breast screening and CAM soy use is needed to verify these associations.
Several methodological concerns need to be considered. These studies were almost all cross-sectional, making it impossible to determine a causal relationship between CAM use and breast screening. Although not all studies found CAM use and breast early detection use were correlated, significant relationships that did emerge were positive. However, this leaves the question of whether higher rates of breast screening result from the holistic and preventive focus of CAM; or whether the individuals who are interested in prevention and early cancer detection are more likely to use CAM; or whether both use of CAM and breast early detection modalities are due to another causal factor, such as self-efficacy for health. Developing and testing conceptual models in this area is a key research priority.
Assessing CAM accurately and consistently is challenging. As seen in Table 2, there was considerable variability among the studies in terms of types of CAM use assessed. In all but one study, CAM use was based on self-reports. The largest study used a sample of over 71,000 women had the advantage of drawing on objective claims reports of services billed to the health insurer which are not subject to recall or social desirability bias; however, only a limited number of CAMs were listed which precluded comparisons with other reports .
Another challenge when comparing CAM research papers is failure to ascertain CAM duration, frequency and dose. For example, a woman who partakes in a yoga session every month for an hour is likely to exhibit different health qualities than another who partakes in a 90-minute session each morning. Frequency and intensity of CAM use may be important to assess.
Researchers who assess nutrition and physical activity are familiar with the difficulties associated with measurement of lifestyle variables. Major advances have been made in these research areas through the introduction of standardized assessment tools that include food frequency and physical activity questionnaires. CAM research would benefit significantly from the introduction of standardized and validated questionnaires that would allow comparisons over time and across studies.
To our knowledge, this is the first review paper examining CAM use and its association with breast cancer screening. Although a majority of women use CAM therapies, and most women also participate in breast cancer early detection, there has been little attention to the overlap between these two phenomena, and the potential for one set of health behaviors to inform the other.
We found a wide variety of findings in populations assessed, and measures used to assess CAM, breast cancer screening, and correlates thereof. Some findings stand out such as the high use of CAM in general and the fact that when there is a significant relationship between CAM use and breast cancer early detection, it tends to be a positive relationship; in other words, women who are motivated to obtain allopathic screening are also motivated to seek out other ways to care for themselves. They tend to be more educated and in better health, and to exhibit better health behaviors, and as such, are availing themselves of a wide range of preventive care. This provides a foundation for future interventions to increase the connection between CAM and allopathic providers, to build on the strengths of what each can offer, and to maximize on patient motivation and preferences to increase breast health and reduce breast cancer risk. Research is needed to make this potential a reality.
The authors gratefully acknowledge the support of the Canadian Cancer Society, British Columbia and Yukon, in this project.
- D. M. Eisenberg, R. B. Davis, S. L. Ettner et al., “Trends in alternative medicine use in the United States, 1990–1997: results of a follow-up national survey,” Journal of the American Medical Association, vol. 280, no. 18, pp. 1569–1575, 1998.
- “National Centre for Complementary and Alternative Medicine, What Is Complementary and Alternative Medicine?” 2011, http://nccam.nih.gov/health/whatiscam.
- P. M. Barnes, B. Bloom, and R. L. Nahin, “Complementary and alternative medicine use among adults and children: United States, 2007,” National Health Statistics Reports, no. 12, pp. 1–23, 2008.
- L. Downey, P. T. Tyree, and W. E. Lafferty, “Preventive screening of women who use complementary and alternative medicine providers,” Journal of Women's Health, vol. 18, no. 8, pp. 1133–1143, 2009.
- D. M. Upchurch, L. Chyu, G. A. Greendale et al., “Complementary and alternative medicine use among American women: findings from the National Health Interview Survey, 2002,” Journal of Women's Health, vol. 16, no. 1, pp. 102–113, 2007.
- R. L. Nahin, J. M. Dahlhamer, B. L. Taylor et al., “Health behaviors and risk factors in those who use complementary and alternative medicine,” BMC Public Health, vol. 7, article 217, 2007.
- C. M. Gray, A. W. Tan, N. P. Pronk, and P. J. O'Connor, “Complementary and alternative medicine use among health plan members. A cross-sectional survey,” Effective Clinical Practice, vol. 5, no. 1, pp. 17–22, 2002.
- J. A. Astin, K. R. Pelletier, A. Marie, and W. L. Haskell, “Complementary and alternative medicine use among elderly persons: one- year analysis of a blue shield Medicare supplement,” The Journals of Gerontology A, vol. 55, no. 1, pp. M4–M9, 2000.
- Globocan, “Breast Cancer Incidence and Mortality Worldwide in 2008 Summary,” 2008, http://globocan.iarc.fr/factsheets/cancers/breast.asp.
- US Preventive Services Task Force, “Screening for Breast Cancer,” 2009, http://www.uspreventiveservicestaskforce.org/uspstf/uspsbrca.htm.
- Canadian Task Force on Preventive Health Care, “Screening for breast cancer,” 2011, http://www.canadiantaskforce.ca/recommendations/2011_01_eng.html.
- (American Cancer Society) Cancer Society, “Breast Cancer: Early Detection,” 2011, http://www.cancer.org/Cancer/BreastCancer/MoreInformation/BreastCancerEarlyDetection/index.
- Canadian Cancer Society, “Breast cancer,” 2011, http://www.cancer.ca/Canada-wide/Prevention/Getting%20checked/Breast%20cancer%20NEW.aspx?sc_lang=en.
- L. M. DiGianni, H. T. Kim, K. Emmons, R. Gelman, K. J. Kalkbrenner, and J. E. Garber, “Complementary medicine use among women enrolled in a genetic testing program,” Cancer Epidemiology Biomarkers and Prevention, vol. 12, no. 4, pp. 321–326, 2003.
- L. M. DiGianni, M. Rue, K. Emmons, and J. E. Garber, “Complementary medicine use before and 1 year following genetic testing for BRCA1/2 mutations,” Cancer Epidemiology Biomarkers and Prevention, vol. 15, no. 1, pp. 70–75, 2006.
- B. G. Druss and R. A. Rosenheck, “Association between use of unconventional therapies and conventional medical services,” Journal of the American Medical Association, vol. 282, no. 7, pp. 651–656, 1999.
- K. M. Field, M. A. Jenkins, M. L. Friedlander et al., “Predictors of the use of complementary and alternative medicine (CAM) by women at high risk for breast cancer,” European Journal of Cancer, vol. 45, no. 4, pp. 551–560, 2009.
- S. Gollschewski, D. Anderson, H. Skerman, and F. Lyons-Wall, “Associations between the use of complementary and alternative medications and demographic, health and lifestyle factors in mid-life Australian women,” Climacteric, vol. 8, no. 3, pp. 271–278, 2005.
- C. M. Mueller, P. L. Mai, J. Bucher, J. A. Peters, J. T. Loud, and M. H. Greene, “Complementary and alternative medicine use among women at increased genetic risk of breast and ovarian cancer,” BMC Complementary and Alternative Medicine, vol. 8, article 17, 2008.
- C. D. Myers, P. B. Jacobsen, Y. Huang et al., “Familial and perceived risk of breast cancer in relation to use of complementary medicine,” Cancer Epidemiology Biomarkers and Prevention, vol. 17, no. 6, pp. 1527–1534, 2008.
- A. R. Robinson, L. A. Crane, A. J. Davidson, and J. F. Steiner, “Association between use of complementary/alternative medicine and health-related behaviors among health fair participants,” Preventive Medicine, vol. 34, no. 1, pp. 51–57, 2002.
- “STROBE Statement. Strengthening the reporting of observational studies in epidemiology,” http://www.strobe-statement.org/.
- K. Brain, P. Norman, J. Gray, and R. Mansel, “Anxiety and adherence to breast self-examination in women with a family history of breast cancer,” Psychosomatic Medicine, vol. 61, no. 2, pp. 181–187, 1999.
- F. L. Bishop and G. T. Lewith, “Who uses CAM a narrative review of demographic characteristics and health factors associated with CAM use,” Evidence-Based Complementary and Alternative Medicine, vol. 7, no. 1, pp. 11–28, 2010.
- C. Lerman, B. Rimer, B. Trock, A. Balshem, and P. F. Engstrom, “Factors associated with repeat adherence to breast cancer screening,” Preventive Medicine, vol. 19, no. 3, pp. 279–290, 1990.
- B. J. Dunigan, T. K. King, and B. J. Morse, “A preliminary examination of the effect of massage on state body image,” Body Image, vol. 8, no. 4, pp. 411–414, 2011.
- M. T. Mandelson, N. Oestreicher, P. L. Porter et al., “Breast density as a predictor of mammographic detection: comparison of interval- and screen-detected cancers,” Journal of the National Cancer Institute, vol. 92, no. 13, pp. 1081–1087, 2000.